Prevalence of anti-SARS-CoV-2 antibody in hemodialysis facilities: a cross-sectional multicenter study from Madinah.

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Accounts of Chemical Research Pub Date : 2022-07-01 Epub Date: 2022-08-04 DOI:10.5144/0256-4947.2022.229
Abdulrahman A Housawi, Shazada Junaid S Qazi, Abdulhalem A Jan, Rashid A Osman, Mashil M Alshamrani, Talal A AlFaadhel, Fayez F AlHejaili, Jaffar A Al-Tawfiq, Ahmed A Wafa, Abdulmageed E Hamza, Moustafa A Hassan, Suliman A Alharbi, Hamza Albasheer, Majed M Almohmmdi, Salem A Alsisi, Michal Mankowski, Joris Van de Klundert, Amal M Alhelal, Fatima H Sala, Ali Kheyami, Bader A Alhomayeed
{"title":"Prevalence of anti-SARS-CoV-2 antibody in hemodialysis facilities: a cross-sectional multicenter study from Madinah.","authors":"Abdulrahman A Housawi,&nbsp;Shazada Junaid S Qazi,&nbsp;Abdulhalem A Jan,&nbsp;Rashid A Osman,&nbsp;Mashil M Alshamrani,&nbsp;Talal A AlFaadhel,&nbsp;Fayez F AlHejaili,&nbsp;Jaffar A Al-Tawfiq,&nbsp;Ahmed A Wafa,&nbsp;Abdulmageed E Hamza,&nbsp;Moustafa A Hassan,&nbsp;Suliman A Alharbi,&nbsp;Hamza Albasheer,&nbsp;Majed M Almohmmdi,&nbsp;Salem A Alsisi,&nbsp;Michal Mankowski,&nbsp;Joris Van de Klundert,&nbsp;Amal M Alhelal,&nbsp;Fatima H Sala,&nbsp;Ali Kheyami,&nbsp;Bader A Alhomayeed","doi":"10.5144/0256-4947.2022.229","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Since the occurrence of coronavirus disease in 2019 (COVID-19), the global community has witnessed its exponential spread with devastating outcomes within the general population and specifically within hemodialysis patients.</p><p><strong>Objectives: </strong>Compare the state of immunity to SARS-CoV-2 among hemodialysis patients and staff.</p><p><strong>Design: </strong>Cross-sectional study with a prospective follow-up period.</p><p><strong>Setting: </strong>Hemodialysis centers in Madinah region.</p><p><strong>Patients and methods: </strong>We prospectively tested for SARS-CoV-2 antibodies in dialysis patients using dialysis centers staff as controls. The participants were tested on four occasions when feasible for the presence of anti-SARS-CoV-2 antibodies. We also analyzed factors that might be associated with seropositivity.</p><p><strong>Main outcome measures: </strong>SARS-CoV-2 positivity using immunoglobulin G (IgG) levels SAMPLE SIZE: 830 participants, 677 patients and 153 dialysis centers staff as controls.</p><p><strong>Results: </strong>Of the total participants, 325 (257 patients and 68 staff) were positive for SARS-CoV-2 IgG antibodies, for a prevalence of 38.0% and 44.4% among patients and staff, respectively (<i>P</i>=.1379). Participants with a history of COVID-19 or related symptoms were more likely to have positive IgG (<i>P</i><.0001). Surprisingly, positivity was also center-dependent. In a multivariable logistic regression, a history of infection and related symptoms contributed significantly to developing immunity.</p><p><strong>Conclusion: </strong>The high prevalence of SARS-CoV-2 antibody among hemodialysis patients and previously asymptomatic staff suggested past asymptomatic infection. Some centers showed more immunity effects than others.</p><p><strong>Limitations: </strong>Unable to collect four samples for each participant; limited to one urban center.</p><p><strong>Conflict of interest: </strong>None.</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":" ","pages":"246-251"},"PeriodicalIF":16.4000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1e/7c/0256-4947.2022.229.PMC9357293.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5144/0256-4947.2022.229","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/8/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Since the occurrence of coronavirus disease in 2019 (COVID-19), the global community has witnessed its exponential spread with devastating outcomes within the general population and specifically within hemodialysis patients.

Objectives: Compare the state of immunity to SARS-CoV-2 among hemodialysis patients and staff.

Design: Cross-sectional study with a prospective follow-up period.

Setting: Hemodialysis centers in Madinah region.

Patients and methods: We prospectively tested for SARS-CoV-2 antibodies in dialysis patients using dialysis centers staff as controls. The participants were tested on four occasions when feasible for the presence of anti-SARS-CoV-2 antibodies. We also analyzed factors that might be associated with seropositivity.

Main outcome measures: SARS-CoV-2 positivity using immunoglobulin G (IgG) levels SAMPLE SIZE: 830 participants, 677 patients and 153 dialysis centers staff as controls.

Results: Of the total participants, 325 (257 patients and 68 staff) were positive for SARS-CoV-2 IgG antibodies, for a prevalence of 38.0% and 44.4% among patients and staff, respectively (P=.1379). Participants with a history of COVID-19 or related symptoms were more likely to have positive IgG (P<.0001). Surprisingly, positivity was also center-dependent. In a multivariable logistic regression, a history of infection and related symptoms contributed significantly to developing immunity.

Conclusion: The high prevalence of SARS-CoV-2 antibody among hemodialysis patients and previously asymptomatic staff suggested past asymptomatic infection. Some centers showed more immunity effects than others.

Limitations: Unable to collect four samples for each participant; limited to one urban center.

Conflict of interest: None.

Abstract Image

Abstract Image

Abstract Image

血液透析设施中抗sars - cov -2抗体的流行:来自麦地那的横断面多中心研究
背景:自2019年冠状病毒病(COVID-19)发生以来,全球社会目睹了其指数级传播,在普通人群中,特别是在血液透析患者中造成了毁灭性的后果。目的:比较血液透析患者与医护人员对SARS-CoV-2的免疫状况。设计:横断面研究,前瞻性随访期。地点:麦地那地区的血液透析中心。患者和方法:以透析中心工作人员为对照,前瞻性检测透析患者的SARS-CoV-2抗体。在可行的情况下,对参与者进行了四次抗sars - cov -2抗体的测试。我们还分析了可能与血清阳性相关的因素。主要结局指标:使用免疫球蛋白G (IgG)水平检测SARS-CoV-2阳性样本大小:830名参与者,677名患者和153名透析中心工作人员作为对照。结果:共有325例(257例患者和68例工作人员)SARS-CoV-2 IgG抗体阳性,患者和工作人员的阳性率分别为38.0%和44.4% (P=.1379)。有COVID-19病史或相关症状的参与者IgG阳性的可能性更大(p)。结论:血液透析患者和既往无症状的工作人员中SARS-CoV-2抗体的高流行率提示既往无症状感染。一些中心比其他中心显示出更多的免疫效果。局限性:无法为每位参与者收集4个样本;仅限于一个城市中心。利益冲突:无。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信